Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07598721 · ClinicalTrials.gov registry record · NA
Ambient AI Clinical Trial
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT07598721 is a NA study that has completed, run by University of Washington. The registered enrollment target is 139 participants.
The verdict
NCT07598721, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
This is a single-site pragmatic randomized control trial studying the effect of ambient artificial intelligence (AI) scribes on the delivery of medical care to patients in the ambulatory setting. The study will last 150 days and include up to 65 providers in the intervention group. Providers will be recruited from three medical specialties, including primary care, oncology, and urology. The study will enroll providers and randomize them to an intervention group (access to the ambient AI scribe product) or a control group (routine patient care). Providers will be evaluated for burnout and task load measures through digital surveys at the beginning, middle, and end of the study. Provider electronic health record (EHR) usage data will also be evaluated for time spent documenting, time spent after hours on days with scheduled clinical care, and time between the start of the clinical encounter and signing it.
Interventions
- OTHER Use of Ambient AI scribe tool on participant's mobile device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2024-12-19 |
| Est. Completion | 2025-07-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07598721
The ClinicalTrials.gov registry entry for NCT07598721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of Ambient AI scribe tool on participant's mobile device is the first listed.
NCT07598721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07598721 about?
NCT07598721 is a clinical study titled "Ambient AI Clinical Trial". This is a single-site pragmatic randomized control trial studying the effect of ambient artificial intelligence (AI) scribes on the delivery of medical care to patients in the ambulatory setting. The study will last 150 days and include up to 65 providers in the intervention group. Providers will be...
What is the current status of trial NCT07598721?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2024-12-19. Estimated completion is 2025-07-04.
What interventions are being tested in trial NCT07598721?
The interventions under investigation include: Use of Ambient AI scribe tool on participant's mobile device (OTHER).
Who is sponsoring clinical trial NCT07598721?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.